Cynata Therapeutics: ASX Investor Series

Company Presentations

by Carolyn Herbert

Cynata Therapeutics Limited (ASX:CYP) Managing Director and CEO Dr Ross Macdonald presents at the ASX Investor Series in Sydney. 
The regenerative medicine company’s presentation is titled, “A Next Generation Stem Cell Company”.
Dr Macdonald outlines Cynata’s key facts and focus and introduces regenerative medicine and the group’s Cymerus™ technology. 
The presentation covers Cynata’s stem cell manufacturing breakthrough and manufacturing issues attracting global attention.
Looking at the industry Dr Macdonald provides a comparison to stem cell company market valuations and discusses the company’s path to revenue.
Dr Macdonald also lists Cynata’s value catalysts and proposition including recent achievements and following priorities.

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.